Cargando…

Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis

Intestinal epithelial cells (IECs) are integral players in homeostasis of immunity and host defense in the gut and are under influence of the intestinal microbiome. Microbial metabolites and dietary components, including short chain fatty acids (acetate, propionate, and butyrate, SCFAs), have an imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schilderink, R., Verseijden, C., de Jonge, W. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730085/ https://www.ncbi.nlm.nih.gov/pubmed/23914191 http://dx.doi.org/10.3389/fimmu.2013.00226

Ejemplares similares

Erratum: Dietary Inhibitors of Histone Deacetylases in Intestinal Immunity and Homeostasis
por: Schilderink, R., et al.
Publicado: (2013)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis
por: Rohrhofer, Johanna, et al.
Publicado: (2021)

Regulatory Effects of Histone Deacetylase Inhibitors on Myeloid-Derived Suppressor Cells
por: Cui, Yudan, et al.
Publicado: (2021)

Epigenetic Regulation of Host Defense Peptide Synthesis: Synergy Between Histone Deacetylase Inhibitors and DNA/Histone Methyltransferase Inhibitors
por: Whitmore, Melanie A., et al.
Publicado: (2022)

Plant-specific histone deacetylases are essential for early and late stages of Medicago nodule development
por: Li, Huchen, et al.
Publicado: (2021)

Regulation of Immune Responses by Histone Deacetylase Inhibitors
por: Licciardi, Paul V., et al.
Publicado: (2012)

Restoring T Cell Tolerance, Exploring the Potential of Histone Deacetylase Inhibitors for the Treatment of Juvenile Idiopathic Arthritis
por: Nijhuis, Lotte, et al.
Publicado: (2019)

Redirection of Epithelial Immune Responses by Short-Chain Fatty Acids through Inhibition of Histone Deacetylases
por: Lin, May Young, et al.
Publicado: (2015)

Checkpoint Blockade Rescues the Repressive Effect of Histone Deacetylases Inhibitors on γδ T Cell Function
por: Bhat, Sajad A., et al.
Publicado: (2018)

Histone deacetylase enzymes and selective histone deacetylase inhibitors for antitumor effects and enhancement of antitumor immunity in glioblastoma
por: Yelton, Caleb J., et al.
Publicado: (2018)

The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
por: Bassett, Shalome A., et al.
Publicado: (2014)

Histone deacetylase 6’s function in viral infection, innate immunity, and disease: latest advances
por: Qu, Min, et al.
Publicado: (2023)

The emerging role of histone deacetylase 1 in allergic diseases
por: Wang, Yongfang, et al.
Publicado: (2022)

Butyrate Histone Deacetylase Inhibitors
por: Steliou, Kosta, et al.
Publicado: (2012)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Fluid-electrolyte homeostasis requires histone deacetylase function
por: Hyndman, Kelly A., et al.
Publicado: (2020)

Clinical Toxicities of Histone Deacetylase Inhibitors
por: Subramanian, Srividya, et al.
Publicado: (2010)

HDAC3 Mediates the Inflammatory Response and LPS Tolerance in Human Monocytes and Macrophages
por: Ghiboub, Mohammed, et al.
Publicado: (2020)

Histone deacetylase inhibitor attenuates intestinal mucosal injury in fatally scalded rats
por: Liu, Rui, et al.
Publicado: (2022)

Dendritic cell development requires histone deacetylase activity
por: Chauvistré, Heike, et al.
Publicado: (2014)

Overview of Histone Deacetylase Inhibitors in Haematological Malignancies
por: Bishton, Mark J., et al.
Publicado: (2010)

CARD9 Signaling in Intestinal Immune Homeostasis and Oncogenesis
por: Hartjes, Lara, et al.
Publicado: (2019)

Histone deacetylase inhibitors as novel anticancer therapeutics
por: Walkinshaw, D.R., et al.
Publicado: (2008)

Intestinal Regulatory T Cells as Specialized Tissue-Restricted Immune Cells in Intestinal Immune Homeostasis and Disease
por: Jacobse, Justin, et al.
Publicado: (2021)

Histone deacetylase inhibitors in multiple myeloma
por: Deleu, Sarah, et al.
Publicado: (2009)

Histone deacetylase inhibitors in Hodgkin lymphoma
por: Buglio, Daniela, et al.
Publicado: (2010)

Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006)

Histone Deacetylase Inhibitors as Anticancer Drugs
por: Eckschlager, Tomas, et al.
Publicado: (2017)

The application of histone deacetylases inhibitors in glioblastoma
por: Chen, Rui, et al.
Publicado: (2020)

Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
por: Hassell, Kelly N.
Publicado: (2019)

Histone deacetylase 4 alters cartilage homeostasis in human osteoarthritis
por: Lu, Jingwei, et al.
Publicado: (2014)

Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer
por: Lian, Bi, et al.
Publicado: (2023)

Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
por: Yan, Wensheng, et al.
Publicado: (2012)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Attenuation of Choroidal Neovascularization by Histone Deacetylase Inhibitor
por: Chan, Nymph, et al.
Publicado: (2015)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
por: Verza, Flávia Alves, et al.
Publicado: (2020)

ER Stress and the UPR in Shaping Intestinal Tissue Homeostasis and Immunity
por: Coleman, Olivia I., et al.
Publicado: (2019)

Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis
por: Sasaki, Izumi, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors and Diabetic Kidney Disease
por: Hadden, Mitchell J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p5ql3q8nkel4vk9677gced7rk8